• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDC27促进T细胞淋巴母细胞淋巴瘤的肿瘤进展并影响程序性死亡受体配体1(PD-L1)的表达。

CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma.

作者信息

Song Yue, Song Wei, Li Zhaoming, Song Wenting, Wen Yibo, Li Jiwei, Xia Qingxin, Zhang Mingzhi

机构信息

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

The Academy of Medical Science of Zhengzhou University, Zhengzhou, China.

出版信息

Front Oncol. 2020 Apr 23;10:488. doi: 10.3389/fonc.2020.00488. eCollection 2020.

DOI:10.3389/fonc.2020.00488
PMID:32391258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190811/
Abstract

T-lymphoblastic lymphoma (T-LBL) is a rare hematological malignancy with highly aggressive, unique clinical manifestations, and poor prognosis. Cell division cycle 27 (CDC27) was previously reported to be a significant subunit of the anaphase-promoting complex/cyclosome. However, the specific functions and relevant mechanisms of CDC27 in T-LBL remain unknown. Through immunohistochemistry staining, we identified that CDC27 was overexpressed in T-LBL tissues and related to tumor progression and poor survival. Functional experiments demonstrated that CDC27 promoted proliferation and . Further experiment suggested the role of CDC27 in facilitating G1/S transition and promoting the expression of Cyclin D1 and CDK4. Then the effect of CDC27 in inhibiting apoptosis was also identified. Furthermore, we found a positive correlation between the expression of CDC27 and Programmed death ligand-1 (PD-L1) by immunohistochemistry staining. The interaction between CDC27 and PD-L1 was also proved by western blot, luciferase gene reporter assay and immunofluorescence. Taken together, our results showed that CDC27 contributes to T-LBL progression and there is a positive correlation between PD-L1 and CDC27, which offers novel perspectives for future studies on targeting CDC27 in T-LBL.

摘要

T淋巴细胞母细胞淋巴瘤(T-LBL)是一种罕见的血液系统恶性肿瘤,具有高度侵袭性、独特的临床表现且预后较差。细胞分裂周期27(CDC27)先前被报道为后期促进复合体/细胞周期体的一个重要亚基。然而,CDC27在T-LBL中的具体功能及相关机制仍不清楚。通过免疫组织化学染色,我们发现CDC27在T-LBL组织中过表达,且与肿瘤进展及不良生存相关。功能实验表明,CDC27促进增殖以及……进一步实验提示CDC27在促进G1/S期转换及促进细胞周期蛋白D1和细胞周期蛋白依赖性激酶4表达方面的作用。随后还确定了CDC27在抑制细胞凋亡方面的作用。此外,通过免疫组织化学染色我们发现CDC27与程序性死亡配体-1(PD-L1)的表达呈正相关。蛋白质免疫印迹法、荧光素酶基因报告基因检测及免疫荧光法也证实了CDC27与PD-L1之间的相互作用。综上所述,我们的结果表明CDC27促进T-LBL进展,且PD-L1与CDC27呈正相关,这为未来针对T-LBL中CDC27的研究提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/7ecff6bfdea7/fonc-10-00488-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/33a5b82988bf/fonc-10-00488-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/893c142685f8/fonc-10-00488-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/353914981db7/fonc-10-00488-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/0d054e4e1285/fonc-10-00488-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/8b9e88db57ab/fonc-10-00488-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/7ecff6bfdea7/fonc-10-00488-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/33a5b82988bf/fonc-10-00488-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/893c142685f8/fonc-10-00488-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/353914981db7/fonc-10-00488-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/0d054e4e1285/fonc-10-00488-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/8b9e88db57ab/fonc-10-00488-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa3e/7190811/7ecff6bfdea7/fonc-10-00488-g0006.jpg

相似文献

1
CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma.CDC27促进T细胞淋巴母细胞淋巴瘤的肿瘤进展并影响程序性死亡受体配体1(PD-L1)的表达。
Front Oncol. 2020 Apr 23;10:488. doi: 10.3389/fonc.2020.00488. eCollection 2020.
2
Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1.细胞分裂周期蛋白27(CDC27)的下调通过p21Cip1/Waf1的积累抑制结肠癌细胞的增殖。
Cell Death Dis. 2016 Jan 28;7(1):e2074. doi: 10.1038/cddis.2015.402.
3
Corrigendum: CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma.勘误:CDC27促进T细胞淋巴母细胞淋巴瘤的肿瘤进展并影响PD-L1表达。
Front Oncol. 2021 Jan 27;10:583698. doi: 10.3389/fonc.2020.583698. eCollection 2020.
4
CDC27 gene expression patterns as a potential biomarker in Acute Leukemia.CDC27 基因表达模式作为急性白血病潜在的生物标志物。
Mol Biol Rep. 2024 Jul 29;51(1):865. doi: 10.1007/s11033-024-09744-7.
5
Depletion of anaphase-promoting complex or cyclosome (APC/C) subunit homolog APC1 or CDC27 of Trypanosoma brucei arrests the procyclic form in metaphase but the bloodstream form in anaphase.布氏锥虫后期促进复合物或细胞周期体(APC/C)亚基同源物APC1或CDC27的缺失会使前循环形式停滞在中期,但使血流形式停滞在后期。
J Biol Chem. 2005 Sep 9;280(36):31783-91. doi: 10.1074/jbc.M504326200. Epub 2005 Jul 1.
6
CDC27 Facilitates Gastric Cancer Cell Proliferation, Invasion and Metastasis via Twist-Induced Epithelial-Mesenchymal Transition.CDC27通过Twist诱导的上皮-间质转化促进胃癌细胞的增殖、侵袭和转移。
Cell Physiol Biochem. 2018;50(2):501-511. doi: 10.1159/000494164. Epub 2018 Oct 11.
7
Molecular structure of the N-terminal domain of the APC/C subunit Cdc27 reveals a homo-dimeric tetratricopeptide repeat architecture.APC/C 亚基 Cdc27 的 N 端结构域的分子结构揭示了同源二聚体四肽重复结构。
J Mol Biol. 2010 Apr 16;397(5):1316-28. doi: 10.1016/j.jmb.2010.02.045. Epub 2010 Mar 3.
8
Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma.靶向p21活化激酶可抑制T细胞淋巴母细胞淋巴瘤的增殖并增强其化疗敏感性。
Blood Sci. 2023 Jul 18;5(4):249-257. doi: 10.1097/BS9.0000000000000169. eCollection 2023 Oct.
9
PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27.PCBP1/HNRNP E1通过对CDC27的翻译调控来保护染色体完整性。
Mol Cancer Res. 2016 Jul;14(7):634-46. doi: 10.1158/1541-7786.MCR-16-0018. Epub 2016 Apr 21.
10
The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis.Cdc20蛋白水解的调控揭示了后期促进复合物组分Cdc23和Cdc27在S期和有丝分裂早期的作用。
Curr Biol. 1998 Jun 18;8(13):750-60. doi: 10.1016/s0960-9822(98)70298-2.

引用本文的文献

1
Advances in CAR-T-cell therapy in T-cell malignancies.嵌合抗原受体 T 细胞疗法在 T 细胞恶性肿瘤中的进展。
J Hematol Oncol. 2024 Jun 24;17(1):49. doi: 10.1186/s13045-024-01568-z.
2
Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma.通过抑制细胞周期蛋白依赖性激酶4/6(CDK4/6)和低氧诱导因子2α(HIF2α)增强默克尔细胞癌的免疫原性反应。
Heliyon. 2023 Dec 10;10(1):e23521. doi: 10.1016/j.heliyon.2023.e23521. eCollection 2024 Jan 15.
3
Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study.

本文引用的文献

1
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway.癌症免疫疗法中针对 PD-1 信号通路的开发与临床应用。
J Biomed Sci. 2019 Dec 5;26(1):96. doi: 10.1186/s12929-019-0588-8.
2
Tandem autologous hematopoietic stem cell transplantation for treatment of adult T-cell lymphoblastic lymphoma: a multiple center prospective study in China.中国多中心前瞻性研究:用于治疗成人 T 细胞淋巴母细胞淋巴瘤的自体造血干细胞移植。
Haematologica. 2021 Jan 1;106(1):163-172. doi: 10.3324/haematol.2019.226985.
3
The anaphase-promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer.
在一项 I 期研究中,评估信迪利单抗(抗 PD-1)在晚期或复发性恶性肿瘤儿科患者中的安全性和临床疗效。
Signal Transduct Target Ther. 2023 Oct 13;8(1):392. doi: 10.1038/s41392-023-01636-9.
4
Circulatory extracellular vesicle derived miR-195-5p promotes cellular apoptosis and suppresses cell proliferation in the buffalo endometrial primary cell culture.循环细胞外囊泡来源的 miR-195-5p 促进水牛子宫内膜原代细胞的细胞凋亡并抑制细胞增殖。
Sci Rep. 2023 Oct 4;13(1):16703. doi: 10.1038/s41598-023-43530-y.
5
The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.从一对双胞胎患者中鉴定结外 NK/T 细胞淋巴瘤的基因特征。
BMC Cancer. 2021 Dec 6;21(1):1303. doi: 10.1186/s12885-021-09023-9.
6
Integrated Analysis of miRNA-mRNA Regulatory Networks Associated with Osteonecrosis of the Femoral Head.与股骨头坏死相关的miRNA-mRNA调控网络的综合分析
Evid Based Complement Alternat Med. 2021 Aug 12;2021:8076598. doi: 10.1155/2021/8076598. eCollection 2021.
7
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study.免疫治疗联合放疗治疗复发性恶性脑胶质瘤:一项前瞻性研究结果。
Front Immunol. 2021 May 7;12:632547. doi: 10.3389/fimmu.2021.632547. eCollection 2021.
8
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer.用于预测胰腺癌患者生存的泛素化相关基因风险模型的鉴定
Front Genet. 2020 Dec 22;11:612196. doi: 10.3389/fgene.2020.612196. eCollection 2020.
后期促进复合物:一种与癌症中发生的体细胞突变相关的关键有丝分裂调节剂。
Genes Chromosomes Cancer. 2020 Mar;59(3):189-202. doi: 10.1002/gcc.22820. Epub 2019 Nov 13.
4
RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer.RBBP8/CtIP 通过与 CtBP 和 BRCA1 在胃癌中相互作用来抑制 P21 的表达。
Oncogene. 2020 Feb;39(6):1273-1289. doi: 10.1038/s41388-019-1060-7. Epub 2019 Oct 21.
5
Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma.由BRD4调控的PD-L1在舌鳞状细胞癌中的表达及临床价值
J Cell Biochem. 2020 Feb;121(2):1855-1869. doi: 10.1002/jcb.29420. Epub 2019 Oct 21.
6
Molecular Profiles and Metastasis Markers in Chinese Patients with Gastric Carcinoma.中国胃癌患者的分子谱和转移标志物。
Sci Rep. 2019 Sep 30;9(1):13995. doi: 10.1038/s41598-019-50171-7.
7
Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer.胰腺癌预后性可变剪接模式的全基因组分析
Front Oncol. 2019 Aug 27;9:773. doi: 10.3389/fonc.2019.00773. eCollection 2019.
8
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.自然杀伤/T 细胞淋巴瘤中 GNAQ 基因 T96S 反复突变。
Nat Commun. 2019 Sep 16;10(1):4209. doi: 10.1038/s41467-019-12032-9.
9
Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma.成人T细胞淋巴母细胞淋巴瘤的基因组与预后分析
Haematologica. 2020 Mar;105(3):e107-e110. doi: 10.3324/haematol.2019.220863. Epub 2019 Aug 14.
10
Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC.循环肿瘤细胞 PD-L1 表达作为 NSCLC 免疫检查点抑制治疗疗效的生物标志物。
Cells. 2019 Aug 1;8(8):809. doi: 10.3390/cells8080809.